Heide Ford
Concepts (340)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Homeodomain Proteins | 30 | 2023 | 495 | 7.770 |
Why?
| Protein Tyrosine Phosphatases | 20 | 2024 | 160 | 5.450 |
Why?
| Breast Neoplasms | 25 | 2025 | 2139 | 3.840 |
Why?
| Epithelial-Mesenchymal Transition | 12 | 2020 | 197 | 3.520 |
Why?
| Gene Expression Regulation, Neoplastic | 28 | 2025 | 1341 | 3.380 |
Why?
| Intracellular Signaling Peptides and Proteins | 15 | 2024 | 431 | 2.670 |
Why?
| Nuclear Proteins | 15 | 2024 | 652 | 2.660 |
Why?
| Triple Negative Breast Neoplasms | 5 | 2025 | 188 | 2.490 |
Why?
| Transforming Growth Factor beta | 7 | 2012 | 465 | 2.100 |
Why?
| Neoplasm Metastasis | 17 | 2025 | 615 | 2.100 |
Why?
| Cell Line, Tumor | 36 | 2025 | 3185 | 2.050 |
Why?
| Neoplastic Stem Cells | 10 | 2025 | 387 | 1.990 |
Why?
| Neoplasms | 15 | 2024 | 2467 | 1.810 |
Why?
| MicroRNAs | 6 | 2018 | 680 | 1.750 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 6 | 2017 | 43 | 1.630 |
Why?
| Vascular Endothelial Growth Factor C | 3 | 2020 | 17 | 1.580 |
Why?
| Cell Transformation, Neoplastic | 6 | 2015 | 328 | 1.390 |
Why?
| Drug Resistance, Neoplasm | 9 | 2017 | 755 | 1.310 |
Why?
| Signal Transduction | 19 | 2025 | 4930 | 1.280 |
Why?
| Muscle Development | 2 | 2022 | 103 | 1.160 |
Why?
| Sarcoma, Ewing | 2 | 2023 | 88 | 1.140 |
Why?
| DNA-Binding Proteins | 6 | 2024 | 1433 | 1.120 |
Why?
| Up-Regulation | 9 | 2018 | 856 | 1.070 |
Why?
| Zebrafish Proteins | 2 | 2022 | 269 | 0.990 |
Why?
| Transcription Factors | 7 | 2022 | 1649 | 0.980 |
Why?
| Mammary Glands, Human | 4 | 2010 | 64 | 0.950 |
Why?
| Chemokine CCL2 | 1 | 2025 | 124 | 0.930 |
Why?
| Animals | 45 | 2025 | 35076 | 0.860 |
Why?
| Protein Phosphatase 2 | 2 | 2024 | 38 | 0.810 |
Why?
| Killer Cells, Natural | 1 | 2025 | 427 | 0.760 |
Why?
| Cerebellar Neoplasms | 1 | 2023 | 155 | 0.760 |
Why?
| Proto-Oncogene Proteins c-myc | 2 | 2024 | 129 | 0.750 |
Why?
| Medulloblastoma | 1 | 2023 | 197 | 0.750 |
Why?
| Rhabdomyosarcoma | 1 | 2022 | 64 | 0.730 |
Why?
| Disease Progression | 4 | 2024 | 2639 | 0.730 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 29 | 0.730 |
Why?
| Neuropilin-2 | 1 | 2020 | 4 | 0.720 |
Why?
| NF-kappa B | 1 | 2025 | 691 | 0.720 |
Why?
| Mammary Neoplasms, Experimental | 5 | 2012 | 67 | 0.710 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 198 | 0.700 |
Why?
| Cell Transdifferentiation | 2 | 2010 | 32 | 0.680 |
Why?
| Mice | 27 | 2025 | 16832 | 0.680 |
Why?
| Cadherins | 2 | 2014 | 189 | 0.660 |
Why?
| Mice, SCID | 8 | 2019 | 349 | 0.650 |
Why?
| Breast | 1 | 2020 | 152 | 0.640 |
Why?
| Pluripotent Stem Cells | 1 | 2020 | 78 | 0.640 |
Why?
| Humans | 67 | 2025 | 130305 | 0.630 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 61 | 0.620 |
Why?
| Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 23 | 0.610 |
Why?
| RNA-Binding Protein EWS | 2 | 2023 | 23 | 0.610 |
Why?
| Transcriptional Activation | 3 | 2018 | 363 | 0.610 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 55 | 0.600 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 14 | 0.600 |
Why?
| Antineoplastic Agents | 5 | 2024 | 2078 | 0.600 |
Why?
| Neoplasm Proteins | 3 | 2018 | 430 | 0.600 |
Why?
| Epithelial Cells | 5 | 2012 | 1075 | 0.590 |
Why?
| Receptor, Notch1 | 1 | 2018 | 63 | 0.580 |
Why?
| Zinc Finger Protein GLI1 | 1 | 2017 | 23 | 0.570 |
Why?
| Mice, Inbred NOD | 6 | 2019 | 586 | 0.560 |
Why?
| Cell Proliferation | 12 | 2024 | 2381 | 0.550 |
Why?
| Anion Transport Proteins | 1 | 2017 | 8 | 0.550 |
Why?
| Paracrine Communication | 1 | 2017 | 62 | 0.550 |
Why?
| Female | 34 | 2025 | 68842 | 0.540 |
Why?
| B7-H1 Antigen | 1 | 2018 | 186 | 0.520 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 57 | 0.520 |
Why?
| Down-Regulation | 2 | 2015 | 642 | 0.520 |
Why?
| Neoplasm Recurrence, Local | 2 | 2019 | 959 | 0.510 |
Why?
| Cell Differentiation | 9 | 2022 | 1896 | 0.500 |
Why?
| Ribosomal Proteins | 1 | 2015 | 76 | 0.490 |
Why?
| Twist-Related Protein 1 | 1 | 2015 | 8 | 0.480 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 121 | 0.480 |
Why?
| Cell Cycle | 4 | 2013 | 587 | 0.480 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2016 | 513 | 0.470 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 572 | 0.470 |
Why?
| Mesoderm | 3 | 2009 | 139 | 0.460 |
Why?
| Epithelium | 3 | 2009 | 313 | 0.450 |
Why?
| Receptors, Transforming Growth Factor beta | 2 | 2012 | 57 | 0.450 |
Why?
| Neoplasm Transplantation | 6 | 2014 | 259 | 0.440 |
Why?
| MCF-7 Cells | 4 | 2020 | 112 | 0.430 |
Why?
| Branchio-Oto-Renal Syndrome | 2 | 2013 | 5 | 0.430 |
Why?
| Interferons | 2 | 2025 | 193 | 0.420 |
Why?
| Transcription, Genetic | 3 | 2014 | 1415 | 0.410 |
Why?
| Molecular Targeted Therapy | 2 | 2015 | 389 | 0.410 |
Why?
| Lung Neoplasms | 3 | 2019 | 2376 | 0.410 |
Why?
| Gene Expression Regulation, Developmental | 5 | 2017 | 825 | 0.400 |
Why?
| Protein Binding | 8 | 2024 | 2120 | 0.400 |
Why?
| Superoxide Dismutase | 1 | 2014 | 330 | 0.400 |
Why?
| Lymphangiogenesis | 1 | 2012 | 26 | 0.390 |
Why?
| Genes, Tumor Suppressor | 1 | 2012 | 87 | 0.390 |
Why?
| Smad7 Protein | 1 | 2012 | 19 | 0.390 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 166 | 0.380 |
Why?
| Mice, Nude | 7 | 2017 | 688 | 0.360 |
Why?
| Genes, Homeobox | 3 | 2022 | 52 | 0.340 |
Why?
| Bone Neoplasms | 1 | 2012 | 228 | 0.330 |
Why?
| Apoptosis | 4 | 2019 | 2519 | 0.330 |
Why?
| Cyclin A | 3 | 2009 | 17 | 0.320 |
Why?
| Embryonic Development | 1 | 2010 | 118 | 0.320 |
Why?
| Mice, Inbred BALB C | 4 | 2019 | 1245 | 0.320 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2025 | 815 | 0.310 |
Why?
| Prognosis | 6 | 2019 | 3830 | 0.300 |
Why?
| Cell Movement | 5 | 2020 | 948 | 0.290 |
Why?
| Genomic Instability | 1 | 2008 | 49 | 0.290 |
Why?
| Tumor Microenvironment | 2 | 2024 | 616 | 0.280 |
Why?
| Gene Regulatory Networks | 2 | 2023 | 283 | 0.270 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1579 | 0.260 |
Why?
| Tyrosine | 2 | 2024 | 220 | 0.260 |
Why?
| Heterografts | 3 | 2017 | 129 | 0.260 |
Why?
| Ovarian Neoplasms | 2 | 2012 | 488 | 0.250 |
Why?
| Retina | 1 | 2008 | 281 | 0.250 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 320 | 0.240 |
Why?
| STAT1 Transcription Factor | 1 | 2025 | 70 | 0.240 |
Why?
| Gene Amplification | 1 | 2005 | 106 | 0.230 |
Why?
| Neoplasm Invasiveness | 3 | 2024 | 484 | 0.230 |
Why?
| rhoA GTP-Binding Protein | 1 | 2024 | 91 | 0.230 |
Why?
| Myosins | 1 | 2024 | 133 | 0.230 |
Why?
| Rosaniline Dyes | 1 | 2024 | 11 | 0.220 |
Why?
| Zebrafish | 2 | 2022 | 465 | 0.220 |
Why?
| Kaplan-Meier Estimate | 2 | 2020 | 869 | 0.220 |
Why?
| Eye Proteins | 1 | 2024 | 87 | 0.220 |
Why?
| Protein Stability | 2 | 2018 | 161 | 0.220 |
Why?
| Cell Hypoxia | 1 | 2024 | 239 | 0.210 |
Why?
| Drug Design | 1 | 2024 | 157 | 0.210 |
Why?
| Enzyme Inhibitors | 5 | 2024 | 832 | 0.210 |
Why?
| Gene Expression Profiling | 4 | 2012 | 1714 | 0.210 |
Why?
| Integrins | 1 | 2023 | 94 | 0.200 |
Why?
| Models, Biological | 4 | 2017 | 1716 | 0.200 |
Why?
| Mitochondrial Proteins | 1 | 2024 | 240 | 0.200 |
Why?
| Myogenin | 1 | 2022 | 13 | 0.200 |
Why?
| MyoD Protein | 1 | 2022 | 32 | 0.190 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 20 | 0.190 |
Why?
| Immunohistochemistry | 3 | 2018 | 1711 | 0.190 |
Why?
| HEK293 Cells | 3 | 2024 | 686 | 0.190 |
Why?
| Brain Neoplasms | 3 | 2024 | 1149 | 0.190 |
Why?
| Cell Survival | 2 | 2017 | 1098 | 0.180 |
Why?
| Transplantation, Heterologous | 3 | 2012 | 190 | 0.180 |
Why?
| Small Molecule Libraries | 2 | 2019 | 86 | 0.180 |
Why?
| Cell Dedifferentiation | 2 | 2010 | 30 | 0.170 |
Why?
| BRCA1 Protein | 1 | 2020 | 63 | 0.170 |
Why?
| Oxygen | 1 | 2024 | 919 | 0.160 |
Why?
| Hedgehog Proteins | 1 | 2020 | 189 | 0.160 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 12 | 0.160 |
Why?
| Cyclin A1 | 3 | 2009 | 5 | 0.150 |
Why?
| Antigens, CD | 2 | 2014 | 483 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 962 | 0.150 |
Why?
| Glioblastoma | 1 | 2021 | 321 | 0.150 |
Why?
| Phosphorylation | 2 | 2024 | 1709 | 0.150 |
Why?
| Tumor Cells, Cultured | 2 | 2019 | 937 | 0.150 |
Why?
| Mutation | 1 | 2009 | 3723 | 0.150 |
Why?
| Cell Growth Processes | 2 | 2008 | 52 | 0.140 |
Why?
| RNA, Small Interfering | 2 | 2017 | 586 | 0.140 |
Why?
| Veratrum Alkaloids | 1 | 2017 | 18 | 0.140 |
Why?
| RNA, Messenger | 3 | 2018 | 2732 | 0.140 |
Why?
| Blotting, Western | 3 | 2011 | 1201 | 0.140 |
Why?
| Maxilla | 1 | 2017 | 33 | 0.140 |
Why?
| Prostatic Neoplasms | 1 | 2024 | 1004 | 0.140 |
Why?
| Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| Proteolysis | 2 | 2017 | 163 | 0.140 |
Why?
| Promoter Regions, Genetic | 3 | 2010 | 1207 | 0.130 |
Why?
| Cellular Reprogramming | 1 | 2017 | 96 | 0.130 |
Why?
| Clone Cells | 1 | 2016 | 258 | 0.130 |
Why?
| Protein Structure, Tertiary | 2 | 2009 | 842 | 0.130 |
Why?
| Multigene Family | 2 | 2008 | 200 | 0.130 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 148 | 0.120 |
Why?
| Allosteric Regulation | 3 | 2024 | 100 | 0.120 |
Why?
| Endothelin-1 | 1 | 2017 | 181 | 0.120 |
Why?
| Tumor Burden | 2 | 2017 | 285 | 0.120 |
Why?
| Receptors, Estrogen | 1 | 2018 | 429 | 0.120 |
Why?
| Trans-Activators | 2 | 2010 | 387 | 0.120 |
Why?
| Structure-Activity Relationship | 3 | 2024 | 541 | 0.120 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.120 |
Why?
| Cell Nucleus | 2 | 2009 | 580 | 0.120 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 634 | 0.120 |
Why?
| Mass Spectrometry | 1 | 2018 | 664 | 0.120 |
Why?
| Claudins | 1 | 2014 | 25 | 0.120 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 130 | 0.120 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2015 | 87 | 0.110 |
Why?
| Gene Expression | 3 | 2009 | 1487 | 0.110 |
Why?
| Genes, MHC Class I | 2 | 2005 | 33 | 0.110 |
Why?
| Survival Rate | 1 | 2019 | 1904 | 0.110 |
Why?
| Autophagy | 1 | 2016 | 269 | 0.110 |
Why?
| RNA Interference | 2 | 2017 | 453 | 0.110 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2549 | 0.110 |
Why?
| Aldehyde Dehydrogenase | 1 | 2014 | 106 | 0.110 |
Why?
| Transfection | 3 | 2017 | 910 | 0.110 |
Why?
| Pyrimidines | 1 | 2017 | 448 | 0.110 |
Why?
| Biomedical Research | 1 | 2020 | 658 | 0.110 |
Why?
| Child | 2 | 2023 | 20961 | 0.110 |
Why?
| Pyridines | 1 | 2017 | 474 | 0.110 |
Why?
| G1 Phase | 1 | 2013 | 71 | 0.110 |
Why?
| Cyclin-Dependent Kinase 6 | 1 | 2013 | 39 | 0.110 |
Why?
| Disease-Free Survival | 1 | 2014 | 658 | 0.100 |
Why?
| Cluster Analysis | 2 | 2012 | 485 | 0.100 |
Why?
| Neuroglia | 1 | 2013 | 166 | 0.100 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2018 | 842 | 0.100 |
Why?
| Antibodies, Neoplasm | 1 | 2012 | 35 | 0.100 |
Why?
| Etoposide | 1 | 2012 | 149 | 0.100 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1196 | 0.100 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2017 | 146 | 0.100 |
Why?
| Reactive Oxygen Species | 1 | 2014 | 587 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 773 | 0.090 |
Why?
| Tissue Array Analysis | 1 | 2011 | 57 | 0.090 |
Why?
| Amino Acid Sequence | 4 | 2014 | 2060 | 0.090 |
Why?
| Repressor Proteins | 1 | 2014 | 402 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 2 | 2024 | 1983 | 0.090 |
Why?
| DNA Damage | 2 | 2017 | 379 | 0.090 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 176 | 0.090 |
Why?
| Energy Metabolism | 1 | 2017 | 841 | 0.090 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 44 | 0.090 |
Why?
| Cell Death | 2 | 2021 | 353 | 0.090 |
Why?
| Lymphatic Metastasis | 1 | 2012 | 319 | 0.090 |
Why?
| Antioxidants | 1 | 2014 | 562 | 0.090 |
Why?
| Doxorubicin | 1 | 2012 | 321 | 0.090 |
Why?
| Protein Domains | 2 | 2024 | 252 | 0.090 |
Why?
| Antigens, Differentiation | 1 | 2010 | 82 | 0.090 |
Why?
| Epigenesis, Genetic | 1 | 2014 | 620 | 0.080 |
Why?
| Metaplasia | 1 | 2009 | 55 | 0.080 |
Why?
| Lymphoma | 1 | 2011 | 194 | 0.080 |
Why?
| Smad3 Protein | 1 | 2009 | 44 | 0.080 |
Why?
| Follow-Up Studies | 1 | 2019 | 4961 | 0.080 |
Why?
| Salivary Proteins and Peptides | 1 | 2009 | 10 | 0.080 |
Why?
| Glioma | 1 | 2013 | 351 | 0.080 |
Why?
| Submandibular Gland | 1 | 2009 | 19 | 0.080 |
Why?
| Mutant Proteins | 1 | 2009 | 98 | 0.080 |
Why?
| Pancreatic Neoplasms | 1 | 2017 | 892 | 0.080 |
Why?
| Lactation | 1 | 2010 | 171 | 0.080 |
Why?
| Protein Structure, Secondary | 1 | 2009 | 339 | 0.070 |
Why?
| Amino Acid Substitution | 1 | 2009 | 287 | 0.070 |
Why?
| Oxidative Stress | 1 | 2014 | 1239 | 0.070 |
Why?
| Eye Neoplasms | 1 | 2008 | 17 | 0.070 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 142 | 0.070 |
Why?
| Protein Transport | 1 | 2009 | 429 | 0.070 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 1015 | 0.070 |
Why?
| Ubiquitin | 1 | 2006 | 63 | 0.070 |
Why?
| Amino Acid Motifs | 1 | 2006 | 211 | 0.060 |
Why?
| Crystallography, X-Ray | 2 | 2019 | 438 | 0.060 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2005 | 18 | 0.060 |
Why?
| Ovary | 1 | 2007 | 214 | 0.060 |
Why?
| Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| Chickens | 1 | 2005 | 188 | 0.060 |
Why?
| Precipitin Tests | 1 | 2004 | 94 | 0.060 |
Why?
| Models, Molecular | 3 | 2019 | 1486 | 0.060 |
Why?
| Cell Line | 2 | 2014 | 2786 | 0.060 |
Why?
| Phylogeny | 2 | 2005 | 847 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2009 | 2107 | 0.060 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2024 | 197 | 0.050 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 32 | 0.050 |
Why?
| Cyclin D1 | 1 | 2003 | 64 | 0.050 |
Why?
| Dogfish | 1 | 2003 | 4 | 0.050 |
Why?
| Cell Lineage | 1 | 2025 | 336 | 0.050 |
Why?
| Molecular Structure | 1 | 2024 | 472 | 0.050 |
Why?
| Fibroblasts | 1 | 2008 | 953 | 0.050 |
Why?
| Sequence Analysis, RNA | 1 | 2025 | 433 | 0.050 |
Why?
| DNA, Complementary | 1 | 2003 | 271 | 0.050 |
Why?
| Single-Cell Analysis | 1 | 2025 | 274 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 5365 | 0.050 |
Why?
| DNA | 1 | 2009 | 1412 | 0.050 |
Why?
| Cell Division | 1 | 2004 | 802 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2012 | 4044 | 0.050 |
Why?
| Neovascularization, Pathologic | 1 | 2004 | 302 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2005 | 467 | 0.050 |
Why?
| Developmental Biology | 1 | 2020 | 21 | 0.040 |
Why?
| Neural Stem Cells | 1 | 2021 | 138 | 0.040 |
Why?
| Cell Plasticity | 1 | 2020 | 28 | 0.040 |
Why?
| Fibrosis | 1 | 2022 | 529 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 2014 | 2854 | 0.040 |
Why?
| Sequence Homology, Amino Acid | 2 | 2014 | 373 | 0.040 |
Why?
| Terminology as Topic | 1 | 2020 | 204 | 0.040 |
Why?
| Peptides | 1 | 2024 | 917 | 0.040 |
Why?
| Treatment Outcome | 1 | 2012 | 10341 | 0.040 |
Why?
| Sp7 Transcription Factor | 1 | 2017 | 8 | 0.040 |
Why?
| Zygoma | 1 | 2017 | 11 | 0.040 |
Why?
| Serrate-Jagged Proteins | 1 | 2017 | 29 | 0.040 |
Why?
| Pregnancy | 1 | 2010 | 6301 | 0.030 |
Why?
| Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.030 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| Branchial Region | 1 | 2017 | 35 | 0.030 |
Why?
| Receptor, Endothelin A | 1 | 2017 | 63 | 0.030 |
Why?
| Consensus | 1 | 2020 | 652 | 0.030 |
Why?
| Craniofacial Abnormalities | 1 | 2017 | 62 | 0.030 |
Why?
| Autophagy-Related Proteins | 1 | 2016 | 41 | 0.030 |
Why?
| Receptors, Notch | 1 | 2017 | 87 | 0.030 |
Why?
| Diphtheria Toxin | 1 | 2016 | 61 | 0.030 |
Why?
| Body Patterning | 1 | 2017 | 128 | 0.030 |
Why?
| Integrases | 1 | 2017 | 119 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2017 | 227 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2016 | 171 | 0.030 |
Why?
| Neural Crest | 1 | 2017 | 121 | 0.030 |
Why?
| DNA Repair | 1 | 2017 | 211 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 290 | 0.030 |
Why?
| Statistics, Nonparametric | 2 | 2009 | 427 | 0.030 |
Why?
| Cell Adhesion | 1 | 2017 | 454 | 0.030 |
Why?
| Adult | 2 | 2015 | 35711 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2016 | 394 | 0.030 |
Why?
| Male | 3 | 2024 | 63748 | 0.030 |
Why?
| Calcium Signaling | 1 | 2017 | 237 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 82 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 67 | 0.030 |
Why?
| Molecular Docking Simulation | 1 | 2014 | 108 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 2016 | 645 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 151 | 0.030 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 24 | 0.030 |
Why?
| Amino Acids | 1 | 2017 | 474 | 0.030 |
Why?
| DNA Primers | 2 | 2005 | 523 | 0.030 |
Why?
| Phenylhydrazines | 1 | 2012 | 3 | 0.030 |
Why?
| Time Factors | 2 | 2017 | 6615 | 0.030 |
Why?
| Miniaturization | 1 | 2012 | 24 | 0.030 |
Why?
| Protein Phosphatase 2C | 1 | 2012 | 15 | 0.030 |
Why?
| Fluoresceins | 1 | 2012 | 47 | 0.030 |
Why?
| Enzyme Assays | 1 | 2012 | 25 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 251 | 0.020 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 45 | 0.020 |
Why?
| Phosphoprotein Phosphatases | 1 | 2012 | 67 | 0.020 |
Why?
| Spleen | 2 | 2005 | 520 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2012 | 171 | 0.020 |
Why?
| Antibody Specificity | 1 | 2012 | 186 | 0.020 |
Why?
| DNA Fragmentation | 1 | 2011 | 46 | 0.020 |
Why?
| Sequence Analysis, DNA | 2 | 2005 | 780 | 0.020 |
Why?
| Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| Mutation, Missense | 1 | 2013 | 321 | 0.020 |
Why?
| High-Throughput Screening Assays | 1 | 2012 | 138 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 361 | 0.020 |
Why?
| Brain | 1 | 2021 | 2629 | 0.020 |
Why?
| Kinetics | 1 | 2012 | 1634 | 0.020 |
Why?
| Tissue Distribution | 1 | 2009 | 297 | 0.020 |
Why?
| Organ Size | 1 | 2009 | 450 | 0.020 |
Why?
| Bursa of Fabricius | 1 | 2005 | 2 | 0.020 |
Why?
| Blotting, Southern | 1 | 2005 | 69 | 0.020 |
Why?
| Sequence Homology | 1 | 2005 | 40 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 202 | 0.020 |
Why?
| Conserved Sequence | 1 | 2005 | 228 | 0.010 |
Why?
| Sequence Alignment | 1 | 2005 | 334 | 0.010 |
Why?
| Chromosome Mapping | 1 | 2005 | 506 | 0.010 |
Why?
| Mice, Knockout | 1 | 2009 | 2811 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 229 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2003 | 536 | 0.010 |
Why?
| Base Sequence | 1 | 2005 | 2162 | 0.010 |
Why?
| Biological Evolution | 1 | 2003 | 428 | 0.010 |
Why?
| Genetic Variation | 1 | 2003 | 939 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2005 | 2074 | 0.010 |
Why?
| Middle Aged | 1 | 2013 | 31322 | 0.010 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|